Cases & Deals

  • Home
  • Practices
  • Changchun High & New Technology Industries Group invests in Rani Therapeutics and negotiates collaboration agreement with Rani

Share

Changchun High & New Technology Industries Group invests in Rani Therapeutics and negotiates collaboration agreement with Rani

October 2017

Client(s) Changchun High & New Technology Industries Group Inc.

Jones Day represented Changchun High & New Technology Industries Group Inc., a manufacturer of biopharmaceuticals and Chinese traditional medicines, in connection with its purchase of Series D Convertible Preferred Stock in a private placement by Rani Therapeutics and negotiation of a collaboration agreement with Rani.

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.